These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21546474)

  • 41. [Clopidogrel protection is not increased further by ASS!].
    Bogousslavsky J
    Praxis (Bern 1994); 2004 Aug; 93(35):1390. PubMed ID: 15468578
    [No Abstract]   [Full Text] [Related]  

  • 42. The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population.
    Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox K; Hennerici M; Mattle HP; Rothwell PM;
    Cerebrovasc Dis; 2009; 27(6):608-13. PubMed ID: 19407444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. North American perspective of antiplatelet agents.
    Gorelick PB
    Adv Neurol; 2003; 92():281-91. PubMed ID: 12760195
    [No Abstract]   [Full Text] [Related]  

  • 44. Stroke: the dashed hopes of neuroprotection.
    Hill MD
    Lancet Neurol; 2007 Jan; 6(1):2-3. PubMed ID: 17166787
    [No Abstract]   [Full Text] [Related]  

  • 45. Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole.
    Weyrich AS; Skalabrin EJ; Kraiss LW
    Am J Ther; 2009; 16(2):164-70. PubMed ID: 19300042
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transient ischaemic attacks: a GP guide.
    Walters MR; Lees KR
    Practitioner; 2001 Jun; 245(1623):481, 484, 488-91 passim. PubMed ID: 11436260
    [No Abstract]   [Full Text] [Related]  

  • 47. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS
    Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of carotid endarterectomy on medical secondary prevention after a stroke or a transient ischemic attack: results from the Reduction of Atherothrombosis for Continued Health (REACH) registry.
    Touzé E; Mas JL; Röther J; Goto S; Hirsch AT; Ikeda Y; Liau CS; Ohman EM; Richard AJ; Wilson PW; Steg PG; Bhatt DL;
    Stroke; 2006 Dec; 37(12):2880-5. PubMed ID: 17068303
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiplatelets in secondary stroke prevention: should clopidogrel be the first choice?
    Aw D; Sharma JC
    Postgrad Med J; 2012 Jan; 88(1035):34-7. PubMed ID: 22121248
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carotid endarterectomy: where do we stand at present?
    Ritter JC; Tyrrell MR
    Curr Opin Cardiol; 2013 Nov; 28(6):619-24. PubMed ID: 24100648
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stroke prevention guidelines look at carotid artery treatments. Updated guidelines also focus on cholesterol and blood pressure control.
    Heart Advis; 2011 Feb; 14(2):5. PubMed ID: 22953366
    [No Abstract]   [Full Text] [Related]  

  • 52. Transient ischaemic attacks: time to wake up.
    Rothwell PM
    Heart; 2007 Aug; 93(8):893-4. PubMed ID: 17639101
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Update on selecting and adjusting antiplatelet therapy for prevention of noncardiogenic, recurrent ischemic stroke.
    Lutsep H
    Expert Rev Cardiovasc Ther; 2011 Oct; 9(10):1295-303. PubMed ID: 21985542
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MATCH results: implications for the internist.
    Lutsep HL
    Am J Med; 2006 Jun; 119(6):526.e1-7. PubMed ID: 16750967
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack.
    Depta JP; Fowler J; Novak E; Katzan I; Bakdash S; Kottke-Marchant K; Bhatt DL
    Stroke; 2012 Sep; 43(9):2376-81. PubMed ID: 22713488
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical inquiries. What is the best management for patients who have a TIA while on aspirin therapy?
    Ahmed N; Coffey JB; Oh R
    J Fam Pract; 2006 Jul; 55(7):627-8. PubMed ID: 16822451
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trends in usage of alternative antiplatelet therapy after stroke and transient ischemic attack.
    Hills NK; Johnston SC
    Stroke; 2008 Apr; 39(4):1228-32. PubMed ID: 18323509
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Guidelines for the management of transient ischemic attacks. From the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks of the Stroke Council of the American Heart Association.
    Stroke; 1994 Jun; 25(6):1320-35. PubMed ID: 8203003
    [No Abstract]   [Full Text] [Related]  

  • 59. Letter by Meves and Neubauer regarding article "Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack".
    Meves SH; Neubauer H
    Stroke; 2012 Nov; 43(11):e167; author reply e168. PubMed ID: 23091124
    [No Abstract]   [Full Text] [Related]  

  • 60. Stroke prevention.
    Sudlow C; Gubitz G; Sandercock P; Lip G
    Clin Evid; 2002 Dec; (8):184-208. PubMed ID: 12603877
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.